Follicle stimulating hormone controls granulosa cell glutamine synthesis to regulate ovulation

Kai-Hui Zhang, Fei-Fei Zhang, Zhi-Ling Zhang, Ke-Fei Fang, Wen-Xing Sun, Na Kong, Min Wu, Hai-Ou Liu, Yan Liu, Zhi Li, Qing-Qing Cai, Yang Wang, Quan-Wei Wei, Peng-Cheng Lin, Yan Lin, Wei Xu, Cong-Jian Xu, Yi-Yuan Yuan, Shi-Min Zhao

PDF(98394 KB)
PDF(98394 KB)
Protein Cell ›› 2024, Vol. 15 ›› Issue (7) : 512-529. DOI: 10.1093/procel/pwad065
RESEARCH ARTICLE

Follicle stimulating hormone controls granulosa cell glutamine synthesis to regulate ovulation

Author information +
History +

Abstract

Polycystic ovary syndrome (PCOS) is the leading cause of anovulatory infertility. Inadequate understanding of the ovulation drivers hinders PCOS intervention. Herein, we report that follicle stimulating hormone (FSH) controls follicular fluid (FF) glutamine levels to determine ovulation. Murine ovulation starts from FF-exposing granulosa cell (GC) apoptosis. FF glutamine, which decreases in pre-ovulation porcine FF, elevates in PCOS patients FF. High-glutamine chow to elevate FF glutamine inhibits mouse GC apoptosis and induces hormonal, metabolic, and morphologic PCOS traits. Mechanistically, follicle-development-driving FSH promotes GC glutamine synthesis to elevate FF glutamine, which maintain follicle wall integrity by inhibiting GC apoptosis through inactivating ASK1-JNK apoptotic pathway. FSH and glutamine inhibit the rapture of cultured murine follicles. Glutamine removal or ASK1-JNK pathway activation with metformin or AT-101 reversed PCOS traits in PCOS models that are induced with either glutamine or EsR1-KO. These suggest that glutamine, FSH, and ASK1-JNK pathway are targetable to alleviate PCOS.

Keywords

ovulation / glutamine / granulosa cells / PCOS / FSH

Cite this article

Download citation ▾
Kai-Hui Zhang, Fei-Fei Zhang, Zhi-Ling Zhang, Ke-Fei Fang, Wen-Xing Sun, Na Kong, Min Wu, Hai-Ou Liu, Yan Liu, Zhi Li, Qing-Qing Cai, Yang Wang, Quan-Wei Wei, Peng-Cheng Lin, Yan Lin, Wei Xu, Cong-Jian Xu, Yi-Yuan Yuan, Shi-Min Zhao. Follicle stimulating hormone controls granulosa cell glutamine synthesis to regulate ovulation. Protein Cell, 2024, 15(7): 512‒529 https://doi.org/10.1093/procel/pwad065

References

[1]
AzzizR, CarminaE, ChenZ. Polycystic ovary syndrome. Nat Rev Dis Primers2016; 2: 16057.
[2]
BaeIH, FooteRH. Utilization of glutamine for energy and protein-synthesis by cultured rabbit follicular oocytes. Exp Cell Res1975; 90: 432-6.
[3]
BarbieriRL. Metformin for the treatment of polycystic ovary syndrome. Obstet Gynecol2003; 101: 785-93.
[4]
ChantranupongL, WolfsonRL, SabatiniDM. Nutrientsensing mechanisms across evolution. Cell 2015; 161: 67-83.
[5]
DasM, DjahanbakhchO, HacihanefiogluB. Granulosa cell survival and proliferation are altered in polycystic ovary syndrome. J Clin Endocrinol Metab 2008; 93: 881-7.
[6]
DevotoL, KohenP, MunozA. Human corpus luteum physiology and the luteal-phase dysfunction associated with ovarian stimulation. Reprod Biomed Online2009; 18: S19-24.
[7]
EfeyanA, CombWC, SabatiniDM. Nutrient-sensing mechanisms and pathways. Nature2015; 517: 302-10.
[8]
FengY, KeC, TangQ. Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling. Cell Death Dis2014; 5 (2): e1088.
[9]
FranksS, McCarthyM. Genetics of ovarian disorders:Polycystic ovary syndrome. Rev Endocr Metab Disord2004; 5: 69-76.
[10]
HeXD, GongW, ZhangJN. Sensing and transmitting intracellular amino acid signals through reversible lysine aminoacylations. Cell Metab2018; 27: 151-166.e6.
[11]
HildpetitoS, WestNB, BrennerRM. Localization of androgen receptor in the follicle and corpus-luteum of the primate ovary during the menstrual-cycle. Biol Reprod1991; 44: 561-8.
[12]
JeongJW, YuC, LeeJH. Subacute toxicity evaluation of KR-33493, FAF1 inhibitor for a new anti-Parkinson’s disease agent, after oral administration in rats and dogs. Regul Toxicol Pharmacol: RTP2016; 81: 387-96.
[13]
KnobilE, NeillJD. Encyclopedia of Reproduction. San Diego:Academic Press, 1998.
[14]
KoYG, KimEK, KimT. Glutamine-dependent antiapoptotic interaction of human glutaminyl-tRNA synthetase with apoptosis signal-regulating kinase 1. J Biol Chem2001; 276: 6030-6.
[15]
LeeS, KangDW, Hudgins-SpiveyS. Theca-specific estrogen receptor-alpha knockout mice lose fertility prematurely. Endocrinology2009; 150: 3855-62.
[16]
LegroRS. Obesity and PCOS: implications for diagnosis and treatment. Semin Reprod Med2012; 30: 496-506.
[17]
LischinskyA, ArmstrongDT. Granulosa-cell stimulation of thecal androgen synthesis. Can J Physiol Pharmacol1983; 61: 472-7.
[18]
MaLW, WeiJW, WanJH. Low glucose and metformin-induced apoptosis of human ovarian cancer cells is connected to ASK1 via mitochondrial and endoplasmic reticulum stress-associated pathways. J Exp Clin Cancer Res2019; 38: 77.
[19]
McCartneyCR, EaglesonCA, MarshallJC. Regulation of gonadotropin secretion: Implications for polycystic ovary syndrome. Semin Reprod Med2002; 20: 317-26.
[20]
MykhalchenkoK, LiznevaD, TrofimovaT. Genetics of polycystic ovary syndrome. Expert Rev Mol Diagn2017; 17: 723-33.
[21]
NestlerJE. Metformin for the treatment of the polycystic ovary syndrome. N Engl J Med2008; 358: 47-54.
[22]
NishiY, YanaseT, MuY. Establishment and characterization of a steroidogenic human granulosa-like tumor cell line, KGN, that expresses functional follicle-stimulating hormone receptor. Endocrinology2001; 142: 437-45.
[23]
PelusiB, GambineriA, PasqualiR. Type 2 diabetes and the polycystic ovary syndrome. Minerva Ginecol2004; 56: 41-51.
[24]
RajuGA, ChavanR, DeenadayalM. Luteinizing hormone and follicle stimulating hormone synergy: a review of role in controlled ovarian hyper-stimulation. J Hum Reprod Sci2013; 6: 227-34.
[25]
ReganSLP, KnightPG, YovichJL. Granulosa cell apoptosis in the ovarian follicle-A changing view. Front Endocrinol2018; 9: 61.
[26]
RisalS, PeiY, LuH. Prenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome. Nat Med2019; 25: 1894-904.
[27]
RobinsonS, RodinDA, DeaconA. Which hormone tests for the diagnosis of polycystic-ovary-syndrome. Br J Obstet Gynaecol1992; 99: 232-8.
[28]
RodriguezParis V, Solon-BietSM, SeniorAM. Defining the impact of dietary macronutrient balance on PCOS traits. Nat Commun2020; 11: 5262.
[29]
Santa-ColomaTA, CrabbJW, ReichertLE Jr. Serine analogues of hFSH-beta-(33-53) and hFSH-beta-(81-95) inhibit hFSH binding to receptor. Biochem Biophys Res Commun1992; 184: 1273-9.
[30]
SasakiH, AsanumaH, FujitaM. Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase. Circulation2009; 119: 2568-77.
[31]
SelvamMKP, BaskaranS, AgarwalA. Proteomics of reproduction: prospects and perspectives. Adv Clin Chem2019; 92: 217-43.
[32]
SkoryRM, XuY, SheaLD. Engineering the ovarian cycle using in vitro follicle culture. Hum Reprod2015; 30: 1386-95.
[33]
TillyJL. Commuting the death sentence: how oocytes strive to survive. Nat Rev Mol Cell Biol2001; 2: 838-48.
[34]
VardhanaSA, ArnoldPK, RosenBP. Glutamine independence is a selectable feature of pluripotent stem cells. Nat Metab2019; 1: 676-87.
[35]
VuguinP, LinderB, RosenfeldRG. The roles of insulin sensitivity, insulin-like growth factor I (IGF-I), and IGF-binding protein-1 and -3 in the hyperandrogenism of AfricanAmerican and Caribbean Hispanic girls with premature adrenarche. J Clin Endocrinol Metab1999; 84: 2037-42.
[36]
WaltersKA, AllanCM, HandelsmanDJ. Rodent models for human polycystic ovary syndrome. Biol Reprod2012; 86: 149, 1-12.
[37]
WangQQ, GuoXC, LiL. Treatment with metformin and sorafenib alleviates endometrial hyperplasia in polycystic ovary syndrome by promoting apoptosis via synergically regulating autophagy. J Cell Physiol2020; 235: 1339-48.
[38]
WasaM, WangHS, TazukeY. Insulin-like growth factor-I stimulates amino acid transport in a glutamine-deprived human neuroblastoma cell line. Biochim Biophys Acta2001; 1525: 118-24.
[39]
Westerterp-PlantengaMS, LejeuneMPGM, NijsI. High protein intake sustains weight maintenance after body weight loss in humans. Int J Obes Relat Metab Disord2004; 28: 57-64.
[40]
WhiteMA, LinCC, RajapaksheK. Glutamine transporters are targets of multiple oncogenic signaling pathways in prostate cancer. Mol Cancer Res2017; 15: 1017-28.
[41]
WuG, HuX, DingJ. The effect of glutamine on Dehydroepiandrosterone-induced polycystic ovary syndrome rats. J Ovarian Res2020; 13: 57.
[42]
XuY, DuncanFE, XuM. Use of an organotypic mammalian in vitro follicle growth assay to facilitate female reproductive toxicity screening. Reprod Fertil Dev2015; 28: 1295-1306.
[43]
YangZ, HackshawA, FengQ. Comparison of gefitinib, erlotinib and afatinib in non-small cell lung cancer: a meta-analysis. Int J Cancer2017; 140: 2805-19.
[44]
ZerpSF, StoterR, KuipersG. AT-101, a small molecule inhibitor of anti-apoptotic Bcl-2 family members, activates the SAPK/JNK pathway and enhances radiation-induced apoptosis. Radiat Oncol2009; 4: 47.
[45]
ZhangH, VollmerM, DeGeyter M. Characterization of an immortalized human granulosa cell line (COV434). Mol Hum Reprod2000; 6: 146-53.
[46]
ZuelkeKA, BrackettBG. Increased glutamine metabolism in bovine cumulus cell-enclosed and denuded oocytes after in vitro maturation with luteinizing hormone. Biol Reprod1993; 48: 815-20.

RIGHTS & PERMISSIONS

2024 The Author(s) 2024. Published by Oxford University Press on behalf of Higher Education Press.
AI Summary AI Mindmap
PDF(98394 KB)

Accesses

Citations

Detail

Sections
Recommended

/